Intech Biopharm Corporation
6461
Rank in Stocks
#20303
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Share Price
$0.7910717
Last synced: 2026-11-10
Market Cap
$87.27M
Change (1 day)
-0.76%
Change (1 year)
59.21%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Intech Biopharm Corporation (6461)
Category
Healthcare
EPS for Intech Biopharm Corporation (6461)
EPS as of June 2026 TTM: $-0.14
According to Intech Biopharm Corporation's latest financial reports, its current EPS (TTM) is $-0.14. At the end of 2025 the company had an EPS of $-0.13, equal to its 2024 EPS of $-0.13.
EPS history for Intech Biopharm Corporation from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.14 | 7.08% |
| 2025 | $-0.13 | -0.08% |
| 2024 | $-0.13 | -10.86% |
| 2023 | $-0.15 | -0.40% |
| 2022 | $-0.15 | -11.80% |
| 2021 | $-0.17 | 21.02% |
| 2020 | $-0.14 | -14.37% |
| 2019 | $-0.16 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -11,350.00% |
US
|
|
| $-7.07 | 4,979.02% |
US
|
|
| $-5.29 | 3,700.29% |
AU
|
|
| $12.88 | -9,352.95% |
BE
|
|
| $21.56 | -15,588.51% |
NL
|
Questions about Intech Biopharm Corporation's earnings per share (EPS)
What is Intech Biopharm Corporation's earnings per share (EPS)?
Intech Biopharm Corporation's earnings per share (EPS) over the last twelve months is $-0.14, as of Jun 2026.
What was Intech Biopharm Corporation's earnings per share (EPS) in 2025?
In 2025, Intech Biopharm Corporation's earnings per share (EPS) was $-0.13, compared with $-0.13 in 2024.
How has Intech Biopharm Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Intech Biopharm Corporation's earnings per share (EPS) was highest in 2025 ($-0.13) and lowest in 2021 ($-0.17).
How does Intech Biopharm Corporation's earnings per share (EPS) compare with similar companies?
Intech Biopharm Corporation's earnings per share (EPS) ($-0.14) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.